Connected Care in North America - 2nd Edition: Market for Connected Medication Management is Gaining Traction

News provided by

Dec 20, 2022, 07:45 ET

DUBLIN, Dec. 20, 2022 /PRNewswire/ -- The "Connected Care in North America - 2nd Edition" report has been added to ResearchAndMarkets.com's offering.

Report Says 31 Million North Americans Used Connected Care Solutions in 2022

How should the mobile industry address the vast business opportunity in the connected care market? The analyst forecasts that the number of cellular connections in the connected care market in North America will increase from 19.6 million in 2021 to more than 36.6 million in 2027. Learn more about how wireless technology can become seamlessly integrated with a medical alert, connected medication management and remote patient monitoring (RPM) solutions in this 145 page in-depth report.

This report has found that around 30.7 million people in North America were using connected care solutions at the end of 2022. The figure refers to users of medical alert systems, connected medication management solutions and remote patient monitoring (RPM) solutions in Canada and the US. RPM is the largest segment of the connected care market with a total of 28.3 million users at the end of 2022.

The market for medical alert systems is considerably smaller with an estimated total of 4.4 million users, whereas the number of connected medication management users reached 1.8 million users at the end of 2022. There is an overlap between the market segments as medical alert users can also be equipped with a medication management solution or an RPM solution, and vice versa. The market is forecasted to grow at a compound annual growth rate (CAGR) of 15.4 percent during the next five years to reach 62.7 million connected care users by 2027.

The market is forecasted to grow at a compound annual growth rate (CAGR) of 18.3 percent during the next six years to reach 49.4 million connected care users by 2024. The leading use cases for RPM have thus far been sleep therapy monitoring. Patients that suffer from sleep-disordered breathing such as obstructive sleep apnea are typically prescribed an airflow generator, including continuous positive airway pressure, bilevel positive airway pressure and automatic positive airway pressure devices. However, many patients find the devices unpleasant to use and poor compliance is common. Payers are increasingly requiring that patients comply with their treatment plans to be reimbursed for the device which has driven equipment providers to connect the devices. ResMed is the largest player of connected airflow generators, partly thanks to the company's decision to include a cellular IoT module as standard in its Air Solutions product family.

Key Market Trends